AUG 21, 2026 · JOURNAL ARTICLE
RNA delivery to the corneal endothelium using charge-altering releasable transporters
Science Advances
Early-phase, uncontrolled mechanistic work demonstrating proof-of-concept for a novel delivery platform in mouse models, human cells in vitro, and one non-human primate, without efficacy endpoints or clinical outcome data.
Study details
DesignPreclinical mechanistic and proof-of-concep…
InterventionCharge-altering releasable transporter (CAR…